-
Many of the generic manufacturers started years back with knock off drugs to sell locally in India, but now the game is changing to where US Pharma is using some of the talent, which costs less than R and D individuals here in the states, to further develop existing work, in other words somewhat continue...
-
Hat's off to the Wall Street Journal for mentioning this. Great topic and I'm going to rant and bring a few more details of this entire issue to light here. As any readers of this blog know I am a tech person that work with medical professionals and others to bring this to light and...
-
This goes back to everyone is in control, yet nobody is in control. The one statement below says it all, technology is out of control, and this is just one example. Do we really know if we are consuming products from cloned animals? Can the FDA tell us this safe? Nobody has the...
-
The device is designed to serve as an alternative to the anticoagulants used to prevent thrombosis during surgery, so no drugs. The device looks to be a potentially safe alternative to medications to keep the blood thin, especially in view of recent news stories on this topic. BD Medical...
-
One cancer drug turned down after many years of research, but the company plans an appeal. The FDA continues to ask for substantial documentation in the hopes of better decision. Refusals don't help the cause when it comes to investors and the potential for continued research. Something...
-
This is an interesting opinion story from an individual that has a natural health site, which many have been criticized over the years as over talking what natural herbs and cures can product as far as results. This particular individual states only 1% of his entire site was related to cancer and...
-
This procedure is not approved for us in the US. It is not inexpensive either at 25-30K per procedure, but good money for the physicians getting paid from 5-7k for their work. There are opinions on both sides of the fence and like anything else today, there has not been one cure all that works...
-
According to the article, this company, Number One Plus condoms, seems to have cornered the market here. This practice appears to be growing in Cambodia. This sounds like new clinical trial territory and something the FDA might want to take a look at (grin). Here's a video of the...
-
Cerner president speaks out about the insurance business, "they need to be redefined". Amgen CEO and President Kevin Sharer called for a better structured FDA . Overall the summary statement says the same thing I have brought up time and time again, who's going to to...
-
As the old saying goes, things roll downhill and Siemens was the straw that broke the camel's back here. Recently Siemens has been in the news with their own issues with restructuring and lay offs. There are other creditors including Clinical Laboratories of Hawaii, Ewa Beach, $3.9 million;...